BYFC vs GILD · rev $184.0K vs P/E 18, rev $7.80B
Broadway Financial Corporation (BYFC) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Broadway Financial Corporation (BYFC) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported BYFC revenue for 2025-12-31 was $184.0K. Net income was -$24.8M. Revenue was up 18.7% from 2024-12-31 to 2025-12-31. BYFC currently screens at market cap $69.4M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BYFC currently screens at market cap $69.4M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BYFC and GILD stock pages for the full models.
Not investment advice.